AAAAAA

   
Results: 1-11 |
Results: 11
HCV AND LYMPHOPROLIFERATIVE DISEASES
Authors: TREPO C BERTHILLON P VITVITSKI L
Citation: C. Trepo et al., HCV AND LYMPHOPROLIFERATIVE DISEASES, Annals of oncology, 9(5), 1998, pp. 469-470
LACK OF EVIDENCE OF HEPATITIS-C INFECTION IN 290 BLOOD COMPONENT RECIPIENTS, DEMONSTRATED BY SEVERAL SINGLE-ANTIGEN RESEARCH IMMUNOASSAYS
Authors: HENRARD DR BERTHILLON P SCHEFFEL JW LADAIQUE PL MOORE BS PAILHOUS MC FINETTI PH TREPO C
Citation: Dr. Henrard et al., LACK OF EVIDENCE OF HEPATITIS-C INFECTION IN 290 BLOOD COMPONENT RECIPIENTS, DEMONSTRATED BY SEVERAL SINGLE-ANTIGEN RESEARCH IMMUNOASSAYS, Transfusion, 38(2), 1998, pp. 194-198
NATURAL-HISTORY OF ACUTE SPORADIC (AS) NON-A,B,C,E HEPATITIS IN BAHIA, BRAZIL
Authors: PARANA R COTRIM H FATMI A BERTHILLON P ANDRADE Z VITVITSKI L TREPO C LYRA L
Citation: R. Parana et al., NATURAL-HISTORY OF ACUTE SPORADIC (AS) NON-A,B,C,E HEPATITIS IN BAHIA, BRAZIL, Hepatology, 24(4), 1996, pp. 1732-1732
INHIBITION OF THE EXPRESSION OF HEPATITIS-A AND HEPATITIS-B VIRUSES (HAV AND HBV) PROTEINS BY INTERFERON IN A HUMAN HEPATOCARCINOMA CELL-LINE (PLC PRF/5)/
Authors: BERTHILLON P CRANCE JM LEVEQUE F JOUAN A PETIT MA DELOINCE R TREPO C
Citation: P. Berthillon et al., INHIBITION OF THE EXPRESSION OF HEPATITIS-A AND HEPATITIS-B VIRUSES (HAV AND HBV) PROTEINS BY INTERFERON IN A HUMAN HEPATOCARCINOMA CELL-LINE (PLC PRF/5)/, Journal of hepatology, 25(1), 1996, pp. 15-19
CLINICAL AND VIROLOGICAL EVALUATION OF PR E-S1 AND PRE-S2 ANTIGEN-DETECTION IN SERUM FROM PATIENTS WITH CHRONIC HEPATITIS-B VIRUS-INFECTION
Authors: ZOULIM F CAPEL F BERTHILLON P TREPO C PETIT MA
Citation: F. Zoulim et al., CLINICAL AND VIROLOGICAL EVALUATION OF PR E-S1 AND PRE-S2 ANTIGEN-DETECTION IN SERUM FROM PATIENTS WITH CHRONIC HEPATITIS-B VIRUS-INFECTION, Gastroenterologie clinique et biologique, 19(12), 1995, pp. 970-975
TREATMENT OF HEPATITIS-C
Authors: TREPO C HABERSETZER F BAILLY F BERBY F PICHOUD C BERTHILLON P VITVITSKI L
Citation: C. Trepo et al., TREATMENT OF HEPATITIS-C, Pathologie et biologie, 43(8), 1995, pp. 716-724
CHARACTERIZATION OF THE 3RD MOST COMMON GENOTYPE OF HEPATITIS-C VIRUSIN FRANCE
Authors: LI JS VITVITSKI L TONG SP MECHAI S BERTHILLON P TREPO C
Citation: Js. Li et al., CHARACTERIZATION OF THE 3RD MOST COMMON GENOTYPE OF HEPATITIS-C VIRUSIN FRANCE, Journal of hepatology, 22, 1995, pp. 74-82
PRES1 ANTIGEN ANTIBODY PATTERNS FOLLOWING INTERFERON THERAPY IN ACUTEAND CHRONIC HEPATITIS-B/
Authors: PETIT MA ZOULIM F BERTHILLON P CAPEL F LI JS DAUGUET C FERRARI C TREPO C
Citation: Ma. Petit et al., PRES1 ANTIGEN ANTIBODY PATTERNS FOLLOWING INTERFERON THERAPY IN ACUTEAND CHRONIC HEPATITIS-B/, Journal of hepatology, 20(1), 1994, pp. 47-56
SYNTHESIS AND ANTIVIRAL ACTIVITY OF NEW CARBONYLPHOSPHONATE 2',3'-DIDEOXY-3'-THIACYTIDINE CONJUGATES
Authors: CHARVET AS TURIN F FAURY P HANTZ O CAMPLO M MOURIER N BERTHILLON P GRACIET JC CHERMANN JC TREPO C KRAUS JL
Citation: As. Charvet et al., SYNTHESIS AND ANTIVIRAL ACTIVITY OF NEW CARBONYLPHOSPHONATE 2',3'-DIDEOXY-3'-THIACYTIDINE CONJUGATES, Antiviral research, 25(2), 1994, pp. 161-168
INTERFERON THERAPY FOR HEPATITIS-C
Authors: TREPO C HABERSETZER F BAILLY F BERBY F PICHOUD C BERTHILLON P VITVITSKI L
Citation: C. Trepo et al., INTERFERON THERAPY FOR HEPATITIS-C, Antiviral research, 24(2-3), 1994, pp. 155-163
EFFICACY OF INTERFERON-ALPHA IN HBV CHRONIC ACTIVE HEPATITIS APPRECIATED BY BRANCHED DNA AMPLIFICATION
Authors: HABERSETZER F ZHANG XX COHARD M BIZOLLON T CHOSSEGROS P BERTHILLON P ROUGIER P CHEVALLIER M URDEA M ZARSKI JP TREPO C
Citation: F. Habersetzer et al., EFFICACY OF INTERFERON-ALPHA IN HBV CHRONIC ACTIVE HEPATITIS APPRECIATED BY BRANCHED DNA AMPLIFICATION, Hepatology, 18(4), 1993, pp. 10000234-10000234
Risultati: 1-11 |